Practice
Featured experience
FTC clearance of Novo Nordisk acquisition of certain Catalent sites
We secured regulatory approval following a lengthy review
Syngenta antitrust litigation victory
We secured the dismissal of a price-fixing antitrust suit
Favorable plea deal for paving company in bid-rigging case
We represented the defendant in a DOJ antitrust investigation, securing a favorable plea deal
Antitrust advice to AI company
We are advising our client on a range of antitrust issues
TE Connectivity $1.4 billion acquisition of Astrodyne TDI
We are advising TE Connectivity on the transaction
Inotiv emerges from chapter 11
We advised an ad hoc group of first-lien lenders in connection with Inotiv’s chapter 11 proceedings
FMC $400 million strategic investment from Tessenderlo Group
We are advising FMC on the transaction
Iridium Communications $8 billion sale to Rocket Lab
We are advising Iridium on the transaction
MSCI acquisition of First Street
We are advising MSCI on the transaction
Sleep Number chapter 11 filing, DIP financing and stalking horse APA
We are representing Sleep Number and its affiliates in their chapter 11 cases
GSK $10.6 billion acquisition of Nuvalent
We are advising GSK on the transaction
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
newcleo combination with NewHold Investment Corp III and PIPE financing
We are advising newcleo on the transaction with the SPAC
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction